Yiming Xu - Concepedia

Concepedia

Author

Yiming Xu

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Weizhen Wu, XU Yi-Ming, Xu Yi‐Ming, Xu, Yiming, Y M Xu, Y. XU, Y. Xu, Yi-Ming Xu, Yi-ming Xu, Yiming Xu

76

Publications

1.9K

Citations

23

H-Index

90

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Temple University Tsinghua University University of Saskatchewan Beijing University of Posts and Telecommunications

YX

About

Yiming Xu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	895
2	Engineering	6	6	517
3	Natural Sciences	6	6	480
4	Health Sciences	2	2	38
5	Public Health	1	1	19

Yiming Xu

×

31

Publications

1.9K

Citations

23

H-Index

	Year	Citations
Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images Kang Zhang, Xiaohong Liu, Jie Xu, Nature Biomedical Engineering Convolutional Neural NetworkEngineeringMachine LearningDeep-learning ModelsIncidence Prediction	2021	291
The crystal structure of human hypoxanthine-guanine phosphoribosyltransferase with bound GMP Janina C. Eads, Giovanna Scapin, Yiming Xu, Cell BiochemistryNatural SciencesBound GmpMolecular BiologyProtein Phosphorylation	1994	195
HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m<sup>6</sup>A-MYC expression Chenchen Hu, Tianyue Liu, Chenying Han, International Journal of Biological Sciences	2021	124
Kinetic Mechanism of Human Hypoxanthine−Guanine Phosphoribosyltransferase: Rapid Phosphoribosyl Transfer Chemistry Yiming Xu, Janina C. Eads, James C. Sacchettini, Biochemistry	1997	104
Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. Vern L. Schramm, Caroline M. Li, Peter C. Tyler, Nature Structural Biology Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	1999	98
Inhibiting the intrinsic pathway of coagulation with a factor XII–targeting RNA aptamer Rebecca S. Woodruff, Yiming Xu, Juliana M. Layzer, Journal of Thrombosis and Haemostasis Rna AptamerImmunologyRna BiologyIntrinsic PathwayGene Expression	2013	94
Chemical defenses of crucifers: elicitation and metabolism of phytoalexins and indole-3-acetonitrile in brown mustard and turnip M. Soledade C. Pedras, Corwin M. Nycholat, Sabine Montaut, Phytochemistry PhytoalexinChemical DefensesBiosynthesisEngineeringBiochemistry	2002	84
1,1′-Ferrocenoyl–oligoprolines. A synthetic, structural and electrochemical study Yiming Xu, P. Saweczko, Heinz‐Bernhard Kraatz Journal of Organometallic Chemistry EngineeringElectrochemical StudyMolecular ElectrochemistryChemistryFunctional Materials	2001	75
Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Antimicrobial Agents and Chemotherapy Medicinal ChemistryAntifungal AgentBiochemistrySpontaneous MutantsAntifungal Agents	2011	75
Ternary complex structure of human hgprtase, prpp, mg<sup>2+</sup>, and the inhibitor HPP reveals the involvement of the flexible loop in substrate binding Ganesaratnam K. Balendiran, José Antonio Moreno Molina, Yiming Xu, Protein Science	1999	69

Page 1